Known risk of benzocaine topical anesthesia in young children?

• A. Methemoglobinemia
• B. Respiratory depression
• C. Hypoglycemia
• D. Allergic reaction

Answer: (A)

Methemoglobinemia is the key risk to understand with benzocaine when used as a topical anesthetic in young children. Benzocaine can oxidize iron in hemoglobin from Fe2+ to Fe3+, creating methemoglobin, which cannot carry oxygen effectively. Infants and young children absorb more topical benzocaine through mucous membranes and have less mature methemoglobin-reductase activity, so they’re more prone to accumulating methemoglobin after exposure.

Clinically, methemoglobinemia may present with cyanosis that doesn’t improve with oxygen, along with fatigue, dizziness, headache, tachycardia, or shortness of breath. If this condition is suspected, stop the benzocaine, provide supportive oxygen, and seek treatment promptly; methylene blue is the antidote for significant cases (with consideration for G6PD deficiency).

Other potential concerns like respiratory depression, hypoglycemia, or allergic reactions are not the characteristic, age-specific risk associated with benzocaine topical anesthesia in young children, making methemoglobinemia the most important concept to recognize in this context.